LAB-X5000 benchtop XRF analyser launched by Hitachi High-Tech Analytical Science

Hitachi High-Tech Analytical Science has launched LAB-X5000, the fastest, easiest to use and most versatile model in the 45-year history of the LAB-X.  LAB-X5000 is a compact benchtop EDXRF (energy dispersive X-ray fluorescence) analyser with a streamlined user interface and the shortest measurement start sequence on the market, designed to deliver high sample throughput with [...]

ALBULA API now available for Windows

ALBULA is a free and versatile viewer and manipulation software for images taken with DECTRIS detectors. Over the years, ALBULA has become an integral part of the experience of using DECTRIS detectors and has spread widely. This was facilitated by the availability of a Python application programming interface (API). With the latest version of ALBULA, [...]

NeoGenomics Joins Thermo Fisher Scientific’s Companion Diagnostic Center of Excellence Program with the Launch of Oncomine™ Dx Target Test

The FDA-approved, next-generation sequencing-based companion diagnostic rapidly identifies non-small cell lung cancer patients eligible for targeted therapies Ft. Myers, Florida –NeoGenomics, Inc. (NASDAQ: NEO), ), a leading global specialty oncology testing laboratory, has signed an agreement with Thermo Fisher Scientific to join the Next-Generation Sequencing Companion Dx Center of Excellence Program (COEP). NeoGenomics is one of [...]

CS Genetics Announces Grant of Intellectual Property

CAMBRIDGE, England CS Genetics Limited, a developer of tools and techniques for genomics, was granted its first patent (GB 2,539,675 B) on 22 November 2017. CS Genetics is developing Coding Strand Sequencing™: a platform for instrument-free, solution-phase indexing of nucleic acids. Coding Strand Sequencing™ uses a new class of macromolecular indexing tool called Coding Strands™ to tag [...]

Purigen Biosystems Appoints Life Science Industry Veteran Barney Saunders, PhD, As Chief Executive Officer

PLEASANTON, Calif. -- Purigen Biosystems, Inc., a company providing next generation technology for extracting, enriching and quantifying nucleic acid from biological samples, today announced that Barney Saunders, PhD, has been appointed Chief Executive Officer and a member of the Board of Directors. Dr. Saunders brings 30 years of experience managing emergent technologies and commercializing disruptive products for life [...]

PerkinElmer and TeakOrigin Team up to Provide Enhanced Transparency in Food

Combines Molecular Spectroscopy Techniques with Analytical Chemistry Expertise to Uncover Nutritional Value of Food WALTHAM, Mass--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with TeakOrigin, a company that integrates technology and data platforms to serve as a detector for food authenticity and quality. PerkinElmer’s cutting-edge molecular spectroscopy instrumentation, [...]

Horizon extends industry-leading gene editing IP portfolio through expansion of CRISPR license rights with ERS Genomics

Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and [...]

Edico Genome’s DRAGEN Secondary Analysis Solutions Now Available Via Seven Bridges

SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges [...]

New England Biolabs® and CasZyme collaborate to enable genome editing applications with novel Cas9 Enzymes

IPSWICH, Mass. and VILNIUS, Lithuania -- New England Biolabs, Inc. (NEB®) and CasZyme, a recently-formed startup company based in Vilnius, Lithuania, announced today that they have entered into a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases, with the goal of providing researchers with additional tools for genome editing and molecular biology applications. Under the terms of the agreement, [...]

Horizon Discovery introduces Multiplex cfDNA Reference Standard for EGFR mutations to support liquid biopsy assays

Location: Cambridge First-to-market cfDNA Reference Standard specific for EGFR gene mutations adds to Horizon’s existing portfolio of cfDNA controls Horizon’s EGFR Multiplex cfDNA Reference Standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays Covers EGFR mutations implicated in the responsiveness to EGFR tyrosine kinase inhibitors and [...]

Access IBO on Knowledge Center